Now showing items 1-10 of 10

    • Prockop, Darwin J.; Oh, Joo Youn; Berkowitz, Barry; Roddy, Gavin W.; Rosa, Robert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-10-23)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Prockop, Darwin J.; Oh, Joo Youn; Roddy, Gavin W.; Rosa, Robert; Berkowitz, Barry A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2014-07-22)
      The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
    • Smith, Jeffrey W.; Romo, Daniel; Ma, Gil; Zancanella, Manuel (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-09-04)
      The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group ...
    • Kao, Cheng C.; Tharachaparamba, Ranjith Kumar (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-11-29)
      The invention relates to compositions and methods related to Toll-like receptor (TLR) polypeptides. In some embodiments, the invention relates to managing TLR3 related diseases. In further embodiments, the invention relates ...
    • Prockop, Darwin J.; Lee, Ryanghwa (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-07-31)
      The present invention provides compositions comprising mesenchymal stem cells (MSCs), and methods for their novel use in the repair of cardiac damage and treatment of inflammatory diseases. The invention also provides ...
    • Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Prockop, Darwin J.; Kim, Dong-Ki; Nishida, Hidetaka; Shetty, Askok K. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-11-02)
      Preparations comprising an enriched population of extracellular vesicles (nEVs) having a negatively charged surface, and that are CD81+ and CD9-, are provided. Improved processes and methods for producing an enriched ...
    • Xu, Xuejun; Hook, Magnus; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-04-07)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...
    • Hook, Magnus; Xu, Xuejun; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-07-23)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...
    • Hook, Magnus; Xu, Xuejun; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-08-28)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...